Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06684249

Efficacy of Nerve Block Versus Botox in Chronic Migraine Management

Led by Zagazig University · Updated on 2024-11-12

64

Participants Needed

1

Research Sites

34 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to determine whether nerve block injections (specifically, supratrochlear and greater occipital nerve injections) are as effective as Botulinum toxin A (Botox) injections in treating chronic migraine in adults. The main questions it aims to answer are: * Do nerve block injections reduce the number of monthly migraine days compared to baseline? * Are there any differences in the frequency of migraine-related symptoms between the nerve block and Botox treatment groups? * Which treatment leads to higher patient satisfaction and improved quality of life? Participants in this study will: * Receive either nerve block injections or Botox injections every 12 weeks. * Visit the clinic once every month for follow-ups and assessments. * Maintain a headache diary to record the frequency and severity of their migraines and any adverse effects experienced. * Researchers will compare the outcomes of the two groups to determine if one treatment is superior in terms of efficacy and patient satisfaction.

CONDITIONS

Official Title

Efficacy of Nerve Block Versus Botox in Chronic Migraine Management

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • Diagnosis of chronic migraine with headaches on 15 or more days per month for over 3 months, including at least 8 migraine days
  • Ability to give informed consent and follow study procedures
  • No changes in preventive migraine medications in the past 3 months
Not Eligible

You will not qualify if you...

  • Allergy or sensitivity to local anesthetics or Botulinum toxin
  • Previous nerve block or Botox treatment within the last 6 months
  • Significant psychiatric or neurological disorders affecting study participation
  • Pregnancy or breastfeeding
  • Contraindications to either treatment based on product guidelines

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zagazig University, Faculty of Medicine

Zagazig, Sharqia Province, Egypt, 44519

Actively Recruiting

Loading map...

Research Team

A

Ahmed A Bessar, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here